ST. JOHN'S, Antigua and Barbuda, Dec. 3, 2025 /PRNewswire/ -- The online trading platform IQ Option is celebrating its 12th anniversary,…
Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, Nov. 28,…
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing…
Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
Jericho, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental…
ST. JOHN'S, Antigua and Barbuda, Sept. 11, 2025 /PRNewswire/ -- IQ Option, an international online broker, has announced its new…
August 22, 2025 12:00 ET | Source: Invivyd WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq:…
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…
August 16, 2025 04:05 ET | Source: Digitalist Group Oyj REGISTRATION OF THE COMBINATION OF SHARES OF DIGITALIST GROUP PLC,…